Bausch Health Companies stock holds near USD 5.70 after earnings beat

Published on 09/23/2026 at 13:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bausch Health Companies stock closed at USD 5.78 on September 18, 2026, up 1.94 percent. Q2 revenue reached USD 2.83 billion and EPS beat estimates.

BHC, CA0717341071, Illustration mit AI erstellt.

Bausch Health Companies Inc. (CA0717341071) closed at USD 5.78 on the NYSE on September 18, 2026, gaining 1.94 percent from the prior close. The move followed quarterly figures showing earnings per share of USD 1.26, above the USD 0.96 consensus estimate.

Quarterly earnings beat estimates

According to MarketBeat on September 23, 2026, Bausch Health reported second-quarter earnings per share of USD 1.26, exceeding the USD 0.96 analyst consensus by USD 0.30. The same report said quarterly revenue reached USD 2.83 billion versus expectations of USD 2.59 billion.

The earnings comparison is the key operating signal: the reported EPS exceeded consensus by 31.25 percent, while revenue was USD 240 million above the estimate. The company had last reported these quarterly results on July 29, 2026, according to MarketBeat.

Growth case meets financial pressure

The earnings beat sits alongside a negative net margin of 10.12 percent and negative return on equity of 561.95 percent for the reported period, figures cited by MarketBeat on September 23, 2026. That contrast matters because the stronger quarterly revenue and EPS do not remove the balance-sheet and profitability pressure reflected in the negative margins.

Growth expectations are linked to the Salix business, including Xifaxan, as well as strategic acquisitions and new product approvals. Zacks described those factors on September 23, 2026 as support for the company's growth prospects. The report did not provide a new price target in the available details.

Stock remains below yearly high

Yahoo Finance reported a 52-week range of USD 4.33 to USD 8.00 and market capitalization of USD 2.121 billion in its September 2026 quote data. The September 18 close of USD 5.78 therefore stood USD 2.22, or 27.75 percent, below the reported 52-week high.

Bausch Health Companies stock closed at USD 5.78 on the NYSE on September 18, 2026, after the 1.94 percent daily gain. The quote data also showed a day range of USD 5.60 to USD 5.72 for the preceding session and volume of 1,854,315 shares.